Skip to main content
OpenTrials
Completed

NCT Number: NCT00641264

Quality of Life Validation in Laryngitis

The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • New Laryngopharyngeal reflux diagnosis less than 1 month or relapsed patients not under current treatment

Exclusion criteria

  • Unable to comply with study requirements.

Treatment and study plan

Omeprazole

Drug

Other names: Losec

Quality of Life Questionnaire

Behavioral

Primary outcomes

  1. LPR-HRQL questionnaire, which measured symptom distress and the effects of LPR on voice, cough, throat clearing, swallow , and overall impact of acid reflux

    Time frame: 2 monthly

Secondary outcomes

  1. Safety assessments via adverse event recording and physical examinations

    Time frame: 2 monthly

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.

Important dates

Study start
2001
Primary completion
2003
Study completion
2003
First posted
Mar 24, 2008
Registry last updated
Jun 11, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.